Rational design of a flavivirus vaccine by abolishing viral RNA 2′-O methylation

Shi Hua Li, Hongping Dong, Xiao Feng Li, Xuping Xie, Hui Zhao, Yong Qiang Deng, Xiao Yu Wang, Qing Ye, Shun Ya Zhu, Hong Jiang Wang, Bo Zhang, Qi Bin Leng, Roland Zuest, E. De Qin, Cheng Feng Qin, Pei-Yong Shi

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Viruses that replicate in the cytoplasm cannot access the host nuclear capping machinery. These viruses have evolved viral methyltransferase( s) to methylate N-7 and 2′-O cap of their RNA; alternatively, they "snatch" host mRNA cap to form the 5′ end of viral RNA. The function of 2′-O methylation of viral RNA cap is to mimic cellular mRNA and to evade host innate immune restriction. A cytoplasmic virus defective in 2′-O methylation is replicative, but its viral RNA lacks 2′-O methylation and is recognized and eliminated by the host immune response. Such a mutant virus could be rationally designed as a live attenuated vaccine. Here, we use Japanese encephalitis virus (JEV), an important mosquito-borne flavivirus, to prove this novel vaccine concept. We show that JEV methyltransferase is responsible for both N-7 and 2′-O cap methylations as well as evasion of host innate immune response. Recombinant virus completely defective in 2′-O methylation was stable in cell culture after being passaged for>30 days. The mutant virus was attenuated in mice, elicited robust humoral and cellular immune responses, and retained the engineered mutation in vivo. A single dose of immunization induced full protection against lethal challenge with JEV strains in mice. Mechanistically, the attenuation phenotype was attributed to the enhanced sensitivity of the mutant virus to the antiviral effects of interferon and IFIT proteins. Collectively, the results demonstrate the feasibility of using 2′-O methylationdefective virus as a vaccine approach; this vaccine approach should be applicable to other flaviviruses and nonflaviviruses that encode their own viral 2′-O methyltransferases.

Original languageEnglish (US)
Pages (from-to)5812-5819
Number of pages8
JournalJournal of Virology
Volume87
Issue number10
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

Flavivirus
Viral RNA
methylation
Methylation
Japanese Encephalitis Virus
Vaccines
RNA
vaccines
Viruses
viruses
RNA Caps
Japanese encephalitis virus
Defective Viruses
methyltransferases
Methyltransferases
live vaccines
mutants
Attenuated Vaccines
Messenger RNA
Flaviviridae

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Rational design of a flavivirus vaccine by abolishing viral RNA 2′-O methylation. / Li, Shi Hua; Dong, Hongping; Li, Xiao Feng; Xie, Xuping; Zhao, Hui; Deng, Yong Qiang; Wang, Xiao Yu; Ye, Qing; Zhu, Shun Ya; Wang, Hong Jiang; Zhang, Bo; Leng, Qi Bin; Zuest, Roland; Qin, E. De; Qin, Cheng Feng; Shi, Pei-Yong.

In: Journal of Virology, Vol. 87, No. 10, 05.2013, p. 5812-5819.

Research output: Contribution to journalArticle

Li, SH, Dong, H, Li, XF, Xie, X, Zhao, H, Deng, YQ, Wang, XY, Ye, Q, Zhu, SY, Wang, HJ, Zhang, B, Leng, QB, Zuest, R, Qin, ED, Qin, CF & Shi, P-Y 2013, 'Rational design of a flavivirus vaccine by abolishing viral RNA 2′-O methylation', Journal of Virology, vol. 87, no. 10, pp. 5812-5819. https://doi.org/10.1128/JVI.02806-12
Li, Shi Hua ; Dong, Hongping ; Li, Xiao Feng ; Xie, Xuping ; Zhao, Hui ; Deng, Yong Qiang ; Wang, Xiao Yu ; Ye, Qing ; Zhu, Shun Ya ; Wang, Hong Jiang ; Zhang, Bo ; Leng, Qi Bin ; Zuest, Roland ; Qin, E. De ; Qin, Cheng Feng ; Shi, Pei-Yong. / Rational design of a flavivirus vaccine by abolishing viral RNA 2′-O methylation. In: Journal of Virology. 2013 ; Vol. 87, No. 10. pp. 5812-5819.
@article{1572a84befae44be99177271a768558e,
title = "Rational design of a flavivirus vaccine by abolishing viral RNA 2′-O methylation",
abstract = "Viruses that replicate in the cytoplasm cannot access the host nuclear capping machinery. These viruses have evolved viral methyltransferase( s) to methylate N-7 and 2′-O cap of their RNA; alternatively, they {"}snatch{"} host mRNA cap to form the 5′ end of viral RNA. The function of 2′-O methylation of viral RNA cap is to mimic cellular mRNA and to evade host innate immune restriction. A cytoplasmic virus defective in 2′-O methylation is replicative, but its viral RNA lacks 2′-O methylation and is recognized and eliminated by the host immune response. Such a mutant virus could be rationally designed as a live attenuated vaccine. Here, we use Japanese encephalitis virus (JEV), an important mosquito-borne flavivirus, to prove this novel vaccine concept. We show that JEV methyltransferase is responsible for both N-7 and 2′-O cap methylations as well as evasion of host innate immune response. Recombinant virus completely defective in 2′-O methylation was stable in cell culture after being passaged for>30 days. The mutant virus was attenuated in mice, elicited robust humoral and cellular immune responses, and retained the engineered mutation in vivo. A single dose of immunization induced full protection against lethal challenge with JEV strains in mice. Mechanistically, the attenuation phenotype was attributed to the enhanced sensitivity of the mutant virus to the antiviral effects of interferon and IFIT proteins. Collectively, the results demonstrate the feasibility of using 2′-O methylationdefective virus as a vaccine approach; this vaccine approach should be applicable to other flaviviruses and nonflaviviruses that encode their own viral 2′-O methyltransferases.",
author = "Li, {Shi Hua} and Hongping Dong and Li, {Xiao Feng} and Xuping Xie and Hui Zhao and Deng, {Yong Qiang} and Wang, {Xiao Yu} and Qing Ye and Zhu, {Shun Ya} and Wang, {Hong Jiang} and Bo Zhang and Leng, {Qi Bin} and Roland Zuest and Qin, {E. De} and Qin, {Cheng Feng} and Pei-Yong Shi",
year = "2013",
month = "5",
doi = "10.1128/JVI.02806-12",
language = "English (US)",
volume = "87",
pages = "5812--5819",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Rational design of a flavivirus vaccine by abolishing viral RNA 2′-O methylation

AU - Li, Shi Hua

AU - Dong, Hongping

AU - Li, Xiao Feng

AU - Xie, Xuping

AU - Zhao, Hui

AU - Deng, Yong Qiang

AU - Wang, Xiao Yu

AU - Ye, Qing

AU - Zhu, Shun Ya

AU - Wang, Hong Jiang

AU - Zhang, Bo

AU - Leng, Qi Bin

AU - Zuest, Roland

AU - Qin, E. De

AU - Qin, Cheng Feng

AU - Shi, Pei-Yong

PY - 2013/5

Y1 - 2013/5

N2 - Viruses that replicate in the cytoplasm cannot access the host nuclear capping machinery. These viruses have evolved viral methyltransferase( s) to methylate N-7 and 2′-O cap of their RNA; alternatively, they "snatch" host mRNA cap to form the 5′ end of viral RNA. The function of 2′-O methylation of viral RNA cap is to mimic cellular mRNA and to evade host innate immune restriction. A cytoplasmic virus defective in 2′-O methylation is replicative, but its viral RNA lacks 2′-O methylation and is recognized and eliminated by the host immune response. Such a mutant virus could be rationally designed as a live attenuated vaccine. Here, we use Japanese encephalitis virus (JEV), an important mosquito-borne flavivirus, to prove this novel vaccine concept. We show that JEV methyltransferase is responsible for both N-7 and 2′-O cap methylations as well as evasion of host innate immune response. Recombinant virus completely defective in 2′-O methylation was stable in cell culture after being passaged for>30 days. The mutant virus was attenuated in mice, elicited robust humoral and cellular immune responses, and retained the engineered mutation in vivo. A single dose of immunization induced full protection against lethal challenge with JEV strains in mice. Mechanistically, the attenuation phenotype was attributed to the enhanced sensitivity of the mutant virus to the antiviral effects of interferon and IFIT proteins. Collectively, the results demonstrate the feasibility of using 2′-O methylationdefective virus as a vaccine approach; this vaccine approach should be applicable to other flaviviruses and nonflaviviruses that encode their own viral 2′-O methyltransferases.

AB - Viruses that replicate in the cytoplasm cannot access the host nuclear capping machinery. These viruses have evolved viral methyltransferase( s) to methylate N-7 and 2′-O cap of their RNA; alternatively, they "snatch" host mRNA cap to form the 5′ end of viral RNA. The function of 2′-O methylation of viral RNA cap is to mimic cellular mRNA and to evade host innate immune restriction. A cytoplasmic virus defective in 2′-O methylation is replicative, but its viral RNA lacks 2′-O methylation and is recognized and eliminated by the host immune response. Such a mutant virus could be rationally designed as a live attenuated vaccine. Here, we use Japanese encephalitis virus (JEV), an important mosquito-borne flavivirus, to prove this novel vaccine concept. We show that JEV methyltransferase is responsible for both N-7 and 2′-O cap methylations as well as evasion of host innate immune response. Recombinant virus completely defective in 2′-O methylation was stable in cell culture after being passaged for>30 days. The mutant virus was attenuated in mice, elicited robust humoral and cellular immune responses, and retained the engineered mutation in vivo. A single dose of immunization induced full protection against lethal challenge with JEV strains in mice. Mechanistically, the attenuation phenotype was attributed to the enhanced sensitivity of the mutant virus to the antiviral effects of interferon and IFIT proteins. Collectively, the results demonstrate the feasibility of using 2′-O methylationdefective virus as a vaccine approach; this vaccine approach should be applicable to other flaviviruses and nonflaviviruses that encode their own viral 2′-O methyltransferases.

UR - http://www.scopus.com/inward/record.url?scp=84877315512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877315512&partnerID=8YFLogxK

U2 - 10.1128/JVI.02806-12

DO - 10.1128/JVI.02806-12

M3 - Article

VL - 87

SP - 5812

EP - 5819

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 10

ER -